Company Description
REST EZ (OTC Link: RTEZ) is a publicly traded pharmaceutical retailers company in the Healthcare sector. The company has a market capitalization of $1.9B.
RTEZ stock has gained 40.0% over the past year.
On a trailing twelve-month basis, REST EZ reported revenue of $0 with net income of -$8K and diluted earnings per share of $0.00.
This page provides a comprehensive overview of RTEZ stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
REST EZ (RTEZ) stock. Over the past 12 months, the stock has gained 40.0%. At a market capitalization of $1.9B, RTEZ is classified as a small-cap stock with approximately 27.5M shares outstanding.
Latest News
SEC Filings
REST EZ has filed 1 recent SEC filing, including 1 Form 10-Q. The most recent filing was submitted on February 9, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all RTEZ SEC filings →
Financial Highlights
operating income reached -$8K, and net income was -$8K. Diluted earnings per share stood at $0.00. The company generated -$45K in operating cash flow.
Upcoming Events
Short Interest History
Short interest in REST EZ (RTEZ) currently stands at 1 shares, representing 0.0% of the float. This relatively low short interest suggests limited bearish sentiment. With 1000.0 days to cover, it would take significant time for short sellers to close their positions based on average trading volume.
Days to Cover History
Days to cover for REST EZ (RTEZ) currently stands at 1000.0 days. This elevated days-to-cover ratio indicates it would take over two weeks of average trading volume for short sellers to exit their positions, suggesting potential for a short squeeze if positive news emerges.
RTEZ Company Profile & Sector Positioning
REST EZ (RTEZ) operates in the Pharmaceutical Retailers industry within the broader Healthcare sector and is listed on the OTC Link.